NPI: 1699857706 · INDIO, CA 92201 · 207RC0000X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 9,645 | $699K |
| 2019 | 12,706 | $1.09M |
| 2020 | 10,806 | $939K |
| 2021 | 12,710 | $1.21M |
| 2022 | 10,785 | $985K |
| 2023 | 14,992 | $1.19M |
| 2024 | 11,280 | $901K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99215 | Prolong outpt/office vis | 25,758 | 18,849 | $1.63M |
| 93306 | 5,392 | 5,373 | $1.30M | |
| 78452 | 2,127 | 2,110 | $732K | |
| 93000 | 17,087 | 14,943 | $473K | |
| 93880 | 2,959 | 2,952 | $472K | |
| 99245 | 2,842 | 2,819 | $367K | |
| 93224 | 3,128 | 3,103 | $361K | |
| A9500 | Tc99m sestamibi | 1,881 | 1,870 | $353K |
| 76705 | 5,322 | 5,304 | $333K | |
| 93925 | 2,941 | 2,933 | $290K | |
| J2785 | Regadenoson injection | 1,197 | 1,189 | $189K |
| 93015 | 2,124 | 2,106 | $177K | |
| 93922 | 2,707 | 2,686 | $149K | |
| J0153 | Adenosine inj 1mg | 1,749 | 881 | $66K |
| 93229 | 49 | 47 | $26K | |
| 99214 | 3,418 | 2,958 | $23K | |
| 95921 | 328 | 325 | $14K | |
| 93010 | 818 | 671 | $11K | |
| 99205 | Prolong outpt/office vis | 197 | 194 | $10K |
| 99407 | 398 | 331 | $9K | |
| A9502 | Tc99m tetrofosmin | 44 | 44 | $8K |
| 99213 | 260 | 252 | $7K | |
| 99244 | 67 | 62 | $6K | |
| 93970 | 27 | 27 | $6K | |
| 99223 | Prolong inpt eval add15 m | 18 | 18 | $2K |
| 96360 | 26 | 26 | $2K | |
| 93228 | 47 | 46 | $782.61 | |
| 93225 | 13 | 13 | $448.81 |